Publisher DOI: 10.1007/s00430-004-0229-y
Title: Complement C3 is required for the progression of cutaneous lesions and neutrophil attraction in Leishmania major infection
Language: English
Authors: Jacobs, Thomas 
Andrä, Jörg 
Gaworski, Iris 
Graefe, Sebastian 
Mellenthin, Katja 
Krömer, Manfred 
Halter, Roman 
Borlak, Jürgen 
Clos, Joachim 
Keywords: Transgenic mice; Cobra venom factor; Leishmania major; Complement C3; Neutrophil
Issue Date: 17-Sep-2004
Publisher: Springer
Journal or Series Name: Medical microbiology and immunology 
Volume: 194
Issue: 3
Startpage: 143
Endpage: 149
Abstract: 
To elucidate the role of complement-mediated uptake in Leishmania major infection in vivo, transgenic BALB/c mice that express the cobra venom factor (CVF) under control of the α1-antitrypsin promoter were infected. CVF expression in these mice leads to a continuous activation and subsequent consumption of complement C3 in the serum. In contrast to susceptible non-transgenic BALB/c mice, CVF-transgenic mice are highly resistant to L. major infection and show a significantly reduced parasite dissemination. Transient depletion of C3 in wild-type BALB/c mice delays progression of lesions for some days. Both CVF-transgenic and non-transgenic mice exhibit similar T cell responses upon infection. However, in CVF-transgenic mice, no infiltration of neutrophils, which were the prominent infiltrating cells at the site of infection in normal susceptible mice, could be detected. We conclude that C3 cleavage is required for the attraction of neutrophils that participate in parasite dissemination.
URI: http://hdl.handle.net/20.500.12738/2020
ISSN: 1432-1831
Review status: This version was peer reviewed (peer review)
Institute: Forschungszentrum Borstel 
Universität Hamburg 
Type: Article
Appears in Collections:Publications without full text

Show full item record

Page view(s)

123
checked on Dec 25, 2024

Google ScholarTM

Check

HAW Katalog

Check

Add Files to Item

Note about this record


Items in REPOSIT are protected by copyright, with all rights reserved, unless otherwise indicated.